Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

In Phispers this week, Eli Lilly became the first pharmaceutical company to reach a market valuation of US$ 1 trillion, driven ...

Impressions : 989

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

In this week’s Phispers, Merck struck a US$ 9.2 billion deal to acquire Cidara Therapeutics to strengthen its infectious-...

Impressions : 679

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

In Phispers this week, Pfizer won its high stakes battle with Novo Nordisk for the obesity-focused biotech Metsera. The deal i...

Impressions : 985

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

As we return from our one-week break due to the CPhI Worldwide, we find our double-dose Phispers edition to be filled with se...

Impressions : 957

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

Otsuka Pharm's Biologics Voyxact Receives Approval in US

Zydus' Generics Verapamil HCl Receives Approval in US

Alembic Pharms' Generics Dapagliflozin Receives Approval in US

Micro's Generics Olmesartan Medoxomil Receives Approval in US

Apotex's Ruxolitinib Receives Approval in US

Inventia Hlthcare Generics Dapagliflozin Receives Approval in US

Alvotech USA's Ustekinumab Receives BLA Approval in US

Aurobindo's Generics Potassium Chloride Receives Approval in US

Xiromed's Generics Clobetasol Propionate Receives Approval in US

Accord BioPharma Ustekinumab Receives BLA Approval in US

FDA Issues Form 483 to North American Custom Laboratories

Wells Pharma of Houston's Receives FDA Warning Letter

Owen Bio's Receives FDA Warning Letter

FDA Issues Form 483 to Fareva Amboise

FDA Issues Form 483 to Immacule Lifesciences

Cdymax Pharma's Receives FDA Warning Letter

Siddha Flower Essences' Receives FDA Warning Letter

RNA Bio Pharma's Receives FDA Warning Letter

RNA Bio/Pharma's Recieves FDA Warning Letter

Cdymax's Receives FDA Warning Letter

Generic HIV Drug Rollout To Take A Hit On Trial Push

Haleon May Rope In Ex-Md Of Castrol India To Head Local Biz

Akums Drugs Names Yuvraj Datta President Of Operational Strategy

Novo Nordisk Cuts Wegovy Prices, Generic Firms Adjust Pricing

Novo Nordisk Seeks FDA Approval for Higher 7.2mg Wegovy Dose

Zydus, RK Pharma Strike Exclusive Deal For Novel Oncology

US Reveals New Medicare Prices For Second Round Of IRA Drugs

FDA Allows Reformulated Ranitidine Back On The Market

Az's Imfinzi Bags Perioperative Nod In Early-Stage Stomach Cancer

Innocan Pharma Reveals Q3 2025 Financials: Revenues Reach $21.6M

Generic HIV Drug Rollout To Take A Hit On Trial Push

Novo Nordisk Cuts Wegovy Prices, Generic Firms Adjust Pricing

FDA Approves SMS Pharma's Reformulated Ranitidine

Pacira Sues WhiteOak, Qilu Pharma Over EXPAREL Patents

Sarepta to Test Elevidys with Immunosuppressive Regimen

Zydus Gets FDA Nod For Verapamil Hydrochloride ER Tablets

Neuland, Lupin, Divi's Lead CDMO Surge Amid U.S. Generics Woes

Marksans Pharma Gets USFDA Nod For Loperamide Tablets

Biocon Pharma Gets FDA Nod For Arthritis Drug Tofacitinib ER

Cosmo, Glenmark Secure Winlevi Market Approval In Europe

Novo Nordisk Seeks FDA Approval for Higher 7.2mg Wegovy Dose

Az's Imfinzi Bags Perioperative Nod In Early-Stage Stomach Cancer

Gan & Lee Starts Ph 3 Trial For 1st Chinese Monthly GLP-1 RA

InnoCare Announces 1st Patient Dosed in Ph 2 Trial of Soficitinib

Eisai Files NDA for Subcutaneous LEQEMBI in Early AD in Japan

GENFIT Announces Appointment Of New Chief Medical Officer

Hong Kong Approves IASO Bio's Fucaso for R/R Myeloma

Intratumoral Therapies Drive Solid Tumor Market to $630.7M

Faron's 2026 Financial Calendar

Celltrion receives Canada approval for Eydenzelt

Dipharma Introduces Method To Detect Nitrosamine formation APIs

Supriya Lifescience Expands Lote Facility With New Module E

HRV Pharma And Metrochem Forge Strategic CDMO Alliance

Antheia links with TAPI to scale biosynthetic drug ingredients

Supply Chain Ties, Bayer Biotech Incubator—Fierce Pharma Asia

Solara's Mangalore facility clears FDA inspection

Celltrion Earmarks $478M To Bolster US Manufacturing Capacity

Successful Approval of CEP Certificate for Lidocaine HCL

Novartis To Set Up Manufacturing Hub In NC, Add 700 Jobs

Import Price Floor On Cards For Critical Pharma Inputs

FDA Grants VAI Status to Biocon's Bengaluru Facility

CDSCO Bans High-Risk Solvents in Pediatric Oral Drugs

Glenmark Pharma Gets VAI From FDA For Monroe Facility

CDSCO Panel Calls For Consistent Drug Standard Enforcement

Telangana DCA Enforces CDSCO Mandate For Drug Safety Reporting

Sanofi Caught Up In Tax Fraud Probe Involving Several Companies

Haryana FDA Hosts Summit on Spurious Drugs, NDPS Fight

Abbott Urgently Corrects Freestyle Libre 3 Sensors Over Safety

Commenters Advocate For Clearer Safety Label Guidance

Lupin Gets 7 Observations From USFDA For Goa Facility

Transmural Systems Secures FDA Breakthrough Approval

GC Genome Blood-Based CRC in American Journal of Gastroenterology

Fangzhou, Tencent Pharma Launch AI Solution For Chronic Disease